What 340BDirect does

340BDirect is a pharmacy-focused software platform that helps contract pharmacies, chain pharmacies, independent pharmacies, and covered entities (hospitals/health systems) participate in the federal 340B drug pricing program. The platform — launched in 2014 as an extension of Procuity's nearly 20-year pharmacy reconciliation technology — provides the systems, tools, data, and controls required to manage 340B programs, including inventory management, accounting reconciliation, HRSA compliance monitoring, audit support, standardized reporting, and EFT fund transfers. Today, the platform connects a network of over 6,500 contract pharmacies with more than 20 third-party administrators and serves covered entities seeking standardized access to compliant pharmacy networks.

The company offers three core product lines: 340BDirect® for Chain Pharmacies (enterprise infrastructure for full-spectrum 340B program management), 340BDirect® for Independent Pharmacies (a no-upfront-cost subscription pathway to 340B participation for smaller pharmacies), and 340BDirect® for Covered Entities (the network-of-networks view), plus a Pharmacy Network finder tool that allows covered entities to search participating contract pharmacies across all 50 U.S. states. Underlying capabilities include NPI-level pharmacy opportunity analysis, standardized data/reporting, and HRSA audit-support tooling. The platform's positioning emphasizes being the "pharmacy advocate" in a 340B ecosystem historically dominated by covered-entity and administrator perspectives.

340BDirect is operated as a division of Zions Bancorporation, N.A. (NASDAQ: ZION), an FDIC-member national bank, through its subsidiary Procuity (PPS Data, LLC DBA Procuity). Revenue is generated via subscription-based SaaS pricing, billed annually with quotes customized by segment; the company uses a sales-led, enterprise-direct go-to-market motion targeting chains, independents, and covered entities via phone/email outreach and a customer portal. The combination of bank backing, multi-decade reconciliation data, and a two-sided network of pharmacies and administrators forms the basis of the company's structural advantages; however, the business operates with a small headcount (11-50) and does not publicly report stand-alone revenue or ARR.

Name

340BDirect

Legal name

340BDirect (Division of Zions Bancorporation, N.A.)

Website

https://340bdirect.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

340BDirect provides subscription-based 340B drug pricing program management software for chain pharmacies, independent pharmacies, and covered entities, supporting a national network of over 6,500 contract pharmacies. It operates as a division of Zions Bancorporation (NASDAQ: ZION) via subsidiary Procuity.

Ownership category

akta.pro rank

Product category

340B Program Management Software

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Software Publishers (513210)

SIC

Services-Prepackaged Software (7372), Services-Management Services (8741)

akta.pro primary industry

340B Program Administration & Contract Pharmacy Services (HLAFALAL)

akta.pro secondary industries

340B Program Administration & Support (HLAEAKAJ), PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL), Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price) (HLAIAKAE), Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

Keywords

• 340B program management
• Contract pharmacy services
• Pharmacy reconciliation software
• 340B compliance platform
• Covered entity connections

Headquarters

HQ city

Murray

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. 340B Program Management SaaS: Subscription-based software-as-a-service platform providing pharmacies with 340B program management tools, compliance monitoring, reporting, and administrator connectivity. Revenue derived from ongoing platform access fees for contract pharmacies and covered entities.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

340BDirect provides the systems, tools, data, and controls to manage 340B drug pricing programs for contract pharmacies and covered entities. The company offers a cloud-based SaaS platform that delivers compliance monitoring, performance analytics, standardized reporting, HRSA audit support, and pharmacy reconciliation, connecting over 6,500 contract pharmacies with covered entities through a network of 20+ 340B administrators.

Product overview

340BDirect® is a unified pharmacy-focused 340B management platform that provides infrastructure, experienced personnel, and tools to help pharmacies manage the complexities of the 340B drug pricing program. The platform consists of three distinct product offerings: 340BDirect® for Chain Pharmacies (enabling chains to take control of their 340B program), 340BDirect® for Independent Pharmacies (enabling independent pharmacies to participate alongside large chain counterparts), and 340BDirect® for Covered Entities (connecting covered entities with a network of over 6,500 contract pharmacies). The platform also includes a Pharmacy Network finder for locating participating pharmacies. Supporting over 6,500 pharmacies and working with over 20 administrators since 2014, the system helps manage financial parameters, program performance, HRSA compliance, and reporting.

Differentiator

Problem solved

Functional benefit

Products and services

• 340BDirect® for Chain Pharmacies
• 340BDirect® for Independent Pharmacies
• 340BDirect® for Covered Entities
• Pharmacy Network

Quantifiable outcome

• Over 6,500 pharmacies supported in the network
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Procuity (PPS Data, LLC DBA Procuity™)coreOthersHealthcare technology company that owns and operates the 340BDirect product. Has brought visibility and financial control to pharmacies for almost 20 years. Parent entity of 340BDirect brand.
• HRSA (Health Resources & Services Administration)minorOthersFederal agency that oversees the 340B drug pricing program. 340BDirect provides compliance support and audit preparation aligned with HRSA guidelines and requirements.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Verity Solutions: Verity Solutions offers a 340B contract pharmacy platform (Verity 340B) with split-billing, accumulation, and audit support — directly comparable to 340BDirect's pharmacy-side compliance and reconciliation tooling.
• RxStrategies: RxStrategies operates a 340B administrator platform serving both covered entities and contract pharmacies with compliance, reporting, and reconciliation — a direct competitor to 340BDirect across shared customer segments.
• CaptureRx: CaptureRx provides 340B contract pharmacy solutions that connect covered entities with retail pharmacies, overlapping directly with 340BDirect's core contract-pharmacy network and reconciliation capabilities.
• Sentry Data Systems: Sentry Data Systems (now part of Craneware) provides 340B management software for hospitals and contract pharmacies with analytics and compliance tools, broadly competing with 340BDirect across the 340B software stack.
• SunRx: SunRx offers a 340B platform (including contract pharmacy administration) targeted at covered entities and pharmacies, with comparable compliance, accumulation, and reporting capabilities.
• PharmaForce: PharmaForce provides 340B compliance and operations solutions for covered entities and contract pharmacies, including reconciliation and reporting — closely comparable to 340BDirect's compliance-focused offerings.
• Macro Helix: Macro Helix provides 340B software (340B Architect) and services focused on contract pharmacy program management and split billing, directly comparable to 340BDirect's pharmacy-side platform.
• Ramsell: Ramsell provides 340B solutions including contract pharmacy program administration and technology, directly comparable to 340BDirect's offering for pharmacies and covered entities.

Broad incumbents

• Wellpartner (McKesson): Wellpartner, now part of McKesson, is a large 340B administrator serving hospitals, FQHCs, and contract pharmacies — a broader incumbent that competes with 340BDirect across both covered-entity and contract-pharmacy segments.

Emerging players

• Therigy: Therigy provides therapy management and specialty pharmacy workflow software, with 340B-adjacent capabilities for specialty and contract pharmacy operations — overlapping with parts of 340BDirect's pharmacy management scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/340BDirect
• Xx.com/340bdirect
• LinkedInlinkedin.com/company/340bdirect

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 340BDirect